Inventor · disambiguated record
Deborah H. Charych
Also filed as: CHARYCH DEBORAH · CHARYCH DEBORAH H
20 granted patents·16 pending applications·920 citations·filing 1996–2025
96Inventor score
Top patents by PatentIndex Score
36 records- 0197US10960079B2Conjugates of an IL-2 moiety and a polymerNEKTAR THERAPEUTICS·Filed 2017·Granted Mar 30, 2021·14 cites·20 claims
- 0296US9861705B2Conjugates of an IL-2 moiety and a polymerBOSSARD MARY J·Filed 2011·Granted Jan 9, 2018·49 cites·18 claims
- 0396US6022748ASol-gel matrices for direct colorimetric detection of analytesSANDIA CORP NEW MEXICO REGENTS·Filed 1997·Granted Feb 8, 2000·288 cites·6 claims
- 0493US8338569B2FGFR extracellular domain acidic region muteinsMARSHALL SHANNON·Filed 2009·Granted Dec 25, 2012·42 cites·5 claims
- 0593US6017390AGrowth of oriented crystals at polymerized membranesUNIV CALIFORNIA·Filed 1997·Granted Jan 25, 2000·143 cites·38 claims
- 0688US10010587B2IL-2Rβ-selective agonists in combination with an anti-CTLA-4 antibody or an anti-PD-1 antibodyNEKTAR THERAPEUTICS·Filed 2015·Granted Jul 3, 2018·11 cites·15 claims
- 0787US6485987B1Sol-gel matrices for direct colorimetric detection of analytesUNIV CALIFORNIA·Filed 2000·Granted Nov 26, 2002·28 cites·23 claims
- 0887US6306598B1Nucleic acid-coupled colorimetric analyte detectorsUNIV CALIFORNIA·Filed 1999·Granted Oct 23, 2001·111 cites·23 claims
- 0983US6001556APolymeric assay film for direct colorimetric detectionUNIV CALIFORNIA·Filed 1996·Granted Dec 14, 1999·66 cites·31 claims
- 1078US12247059B2Conjugates of an IL-2 moiety and a polymerNEKTAR THERAPEUTICS·Filed 2021·Granted Mar 11, 2025·0 cites·15 claims
- 1177US6103217APolymeric assemblies for sensitive colorimetric assaysUNIV CALIFORNIA·Filed 1997·Granted Aug 15, 2000·38 cites·39 claims
- 1276US10786552B2Il-2Rβ-selective agonists in combination with an anti-CTLA-4 antibody or an anti-PD-1 antibodyNEKTAR THERAPEUTICS·Filed 2018·Granted Sep 29, 2020·1 cites·18 claims
- 1376US2025304641A1Conjugates of an il-2 moiety and a polymerNEKTAR THERAPEUTICS·Filed 2025·Application pending·0 cites
- 1474US6468759B1Direct colorimetric detection of biocatalystsUNIV CALIFORNIA·Filed 1998·Granted Oct 22, 2002·42 cites·16 claims
- 1574US6183772B1Doped colorimetric assay liposomesUNIV CALIFORNIA·Filed 1996·Granted Feb 6, 2001·41 cites·21 claims
- 1669US2021023230A1Conjugates of an il-2 moiety and a polymerNEKTAR THERAPEUTICS·Filed 2020·Application pending·0 cites
- 1766US10653689B2Combination-based treatment methodNEKTAR THERAPEUTICS·Filed 2015·Granted May 19, 2020·1 cites·11 claims
- 1866US2025064996A1Stabilized compositions of radionuclides and uses thereofRAYZEBIO INC·Filed 2024·Application pending·0 cites
- 1962US2020368321A1Il-2rbeta-selective agonists in combination with an anti-ctla-4 antibody or an anti-pd-1 antibodyNEKTAR THERAPEUTICS·Filed 2020·Application pending·0 cites
- 2061US2023158179A1Radiopharmaceutical conjugate compositions and uses thereofRAYZEBIO INC·Filed 2022·Application pending·0 cites
- 2159US6395561B1Polymeric assay film for direct colorimetric detectionUNIV CALIFORNIA·Filed 1999·Granted May 28, 2002·21 cites·15 claims
- 2259US2019030182A1Water-soluble polymer-linked binding moiety and drug compoundsNEKTAR THERAPEUTICS·Filed 2018·Application pending·0 cites
- 2358US6180135B1Three-dimensional colorimetric assay assembliesUNIV CALIFORNIA·Filed 1997·Granted Jan 30, 2001·24 cites·25 claims
- 2457US2025270273A1Polymer engineered forms of interferon-gamma and methods of useNEKTAR THERAPEUTICS·Filed 2022·Application pending·0 cites
- 2555US2014088021A1Water-Soluble Polymer-Linked Binding Moiety and Drug CompoundsRIGGS-SAUTHIER JENNIFER·Filed 2012·Application pending·0 cites
- 2653US9175065B2FGFR extracellular domain acidic region muteinsMARSHALL SHANNON·Filed 2012·Granted Nov 3, 2015·0 cites·9 claims
- 2751US2020237747A1Combination-based treatment methodNEKTAR THERAPEUTICS·Filed 2020·Application pending·0 cites
- 2848US2003129618A1Sensitive and rapid detection of pathogenic organisms and toxins using fluorescent polymeric lipidsUNIV CALIFORNIA·Filed 2002·Application pending·0 cites
- 2948US2020317784A1Methods and compositions for treating cancer by modifying multiple arms of the immune systemBIOXCEL THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 3047US11318164B2Immunotherapeutic treatment method using an interleukin-2 receptor beta-selective agonist in combination with adoptive cell transfer therapyNEKTAR THERAPEUTICS·Filed 2018·Granted May 3, 2022·0 cites·25 claims
- 3146US2021355223A1Combinations for Treating CancerPFIZER·Filed 2019·Application pending·0 cites
- 3242US2021386826A1Combination for Treating CancerPFIZER·Filed 2019·Application pending·0 cites
- 3340US2019275133A1Immunotherapeutic tumor treatment methodNEKTAR THERAPEUTICS·Filed 2017·Application pending·0 cites
- 3437US12233104B2Combination of an IL-2RBETA-selective agonist and a long-acting IL-15 agonistNEKTAR THERAPEUTICS·Filed 2016·Granted Feb 25, 2025·0 cites·14 claims
- 3535US2019290733A1Conjugates of an il-7 moiety and a polymerNEKTAR THERAPEUTICS·Filed 2016·Application pending·0 cites
- 3633US2017035898A1Conjugates of an il-15 moiety and a polymerNEKTAR THERAPEUTICS·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →